EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

CXCR4-Targeted Nanotherapeutics: A Promising Approach for Liver Fibrosis and Hepatocellular Carcinoma Management

Aftab Ullah iD, Marina Khan, Yibang Zhang iD, Muhammad Shafiq iD, Mohsan Ullah, Azar Abbas iD, Kifayat Ullah, Xu Xiangxiang, Gang Chen, Yong Diao iD

International Journal of Nanomedicine · 2026-04 · Volume 21 · 1-39

DOI: 10.2147/ijn.s586165 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026-04. Verfasst von Aftab Ullah und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Huaqiao University, Quanzhou, Fujian, People's Republic of China. Hauptthemen laut MEDLINE: Receptors, CXCR4, Liver Neoplasms, Carcinoma, Hepatocellular, Liver Cirrhosis. Die Arbeit nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CXCR4Liver NeoplasmsCarcinoma, HepatocellularLiver CirrhosisNanoparticlesHumansAnimalsMolecular Targeted TherapyDrug Delivery SystemsSignal TransductionAntineoplastic Agents

Stichwörter der Autor:innen

CXCR targeted drug delivery systemsCXCR4HCCHSCsLF

Substanzen

Receptors, CXCR4CXCR4 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • School of Medicine, Huaqiao University, Quanzhou, Fujian, People's Republic of China.
  • Department of Biotechnology and Genetic Engineering, Kohat University of Science and Technology, Kohat, Khyber Pakhtunkhwa, Pakistan.
  • School of Pharmacy, Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.
  • Research Institute of Clinical Pharmacy, Shantou University Medical College, Shantou, Guangdong, People's Republic of China.
  • Institute of Medicine, Shenzhen Institute of Advanced Technology, Shenzhen, Guangdong, People's Republic of China.
  • School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, Qingdao, Shandong, People's Republic of China.

ORCID-Profile: Aftab Ullah, Yibang Zhang, Muhammad Shafiq, Azar Abbas, Yong Diao

Zitieren

APA

Ullah, A., Khan, M., Zhang, Y., Shafiq, M., Ullah, M., Abbas, A., Ullah, K., Xiangxiang, X., Chen, G., & Diao, Y. (2026). CXCR4-Targeted Nanotherapeutics: A Promising Approach for Liver Fibrosis and Hepatocellular Carcinoma Management. International Journal of Nanomedicine, Volume 21, 1-39. https://doi.org/10.2147/ijn.s586165

Vancouver

Ullah A, Khan M, Zhang Y, Shafiq M, Ullah M, Abbas A, et al. CXCR4-Targeted Nanotherapeutics: A Promising Approach for Liver Fibrosis and Hepatocellular Carcinoma Management. International Journal of Nanomedicine. 2026;Volume 21:1-39. doi:10.2147/ijn.s586165

BibTeX
@article{Ullah2026,
  author = {Ullah, Aftab and Khan, Marina and Zhang, Yibang and Shafiq, Muhammad and Ullah, Mohsan and Abbas, Azar and Ullah, Kifayat and Xiangxiang, Xu and Chen, Gang and Diao, Yong},
  title = {CXCR4-Targeted Nanotherapeutics: A Promising Approach for Liver Fibrosis and Hepatocellular Carcinoma Management},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  volume = {Volume 21},
  pages = {1--39},
  doi = {10.2147/ijn.s586165}
}
Kostenlos starten →